Congress Pushes US FDA On Trial Diversity, Accelerated Approval In Approps Report

colorful ropes joining together
Congress again raises concerns about a lack of alignment among the FDA's drugs and biologics centers in its appropriations report. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet